Illumina Inc. (NASDAQ:ILMN) reported fourth-quarter 2013 adjusted earnings per share (EPS) of 45 cents, beating the Zacks Consensus Estimate by a penny. Earnings also exceeded the year-ago quarter figure by 7.1%. Illumina, Inc. (NASDAQ:ILMN) stock opened at $142.98 in last session, and closed at $146.67, while the day range of stock is $140.05 – $154.99. The stock showed a positive weekly performance of 1.34%.
One company that hasn’t been getting as much attention as it probably should is Prana Biotechnology Limited (ADR) (NASDAQ:PRAN). Over the past two years, shares of Prana Biotechnology have soared by approximately 440 percent. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) stock opened at $9.82, in last session and closed at $10.23, by gaining 2.71%. The 52 week range of the stock is $9.41 – $10.89. Company’s market capitalization is $416.78 million.
In company news, Imprimis Pharmaceuticals Inc. (NASDAQ:IMMY) rallied Tuesday, trading more than 8% higher in late trade after the drug-maker said it will exhibit its precommercial ophthalmic formulations at an upcoming industry conference starting later this week. Imprimis Pharmaceuticals Inc (NASDAQ:IMMY) stock decreased -2.92% and finished the last session at $7.98. The EPS of the stock remained -0.88. Company’s market capitalization is $71.58 million.
InfuSystem Holdings, Inc. (NYSE MKT:INFU), a leading national provider of infusion pumps and related services for the healthcare industry in the United States, announced it has successfully implemented a complete data integration project with Advanced Medical Specialties (AMS), a foremost Oncology practice in Miami, FL, that eliminates administrative overhead and is already delivering significant time savings for the staff at AMSInfuSystem Holdings Inc (NYSEMKT:INFU) stock opened the session at $2.60, and closed the session at $2.66. The 52 week range of the stock remained $1.27 – $2.88 and the day range was $2.53 – $2.67.
Leave a Reply